| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner
9 companies
Opaleye Management Inc. is a 10% Owner at CDXS with holdings across 9 companies. Recent SEC Form 4 filings include 28 buys and 0 sells.
Estimated insider holdings value: $139.5M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2022 | TELA Tela Bio, Inc. | 10% Owner | Buy | 3,567 | $7.00 | $24,968.98 | +0.1% | +21.0% | +44.5% | |
| Jun 22, 2022 | TELA Tela Bio, Inc. | 10% Owner | Buy | 2,400 | $6.99 | $16,776.00 | +0.1% | +29.2% | +66.9% | |
| Jun 22, 2022 | TELA Tela Bio, Inc. | 10% Owner | Buy | 52,400 | $6.50 | $340,573.80 | +3.3% | +29.2% | +66.9% | |
| Jun 10, 2022 | TELA Tela Bio, Inc. | 10% Owner | Buy | 27,500 | $5.60 | $154,066.00 | +1.8% | +55.5% | +92.3% | |
| Apr 13, 2022 | HROW Harrow, Inc. | 10% Owner | Buy | 41,389 | $6.75 | $279,502.30 | +0.6% | +3.8% | +226.4% | |
| Apr 8, 2022 | TARA Protara Therapeutics, Inc. | 10% Owner | Buy | 10,136 | $4.78 | $48,486.88 | +0.2% | -34.7% | -41.4% | |
| Jan 28, 2022 | HROW Harrow, Inc. | 10% Owner | Buy | 6,343 | $6.89 | $43,686.14 | +0.2% | -2.2% | +113.5% | |
| Jan 28, 2022 | TARA Protara Therapeutics, Inc. | 10% Owner | Buy | 24,031 | $4.96 | $119,270.66 | +0.9% | -25.3% | -38.6% | |
| Dec 29, 2021 | TARA Protara Therapeutics, Inc. | 10% Owner | Buy | 11,591 | $6.60 | $76,498.00 | +0.4% | -14.1% | -55.1% | |
| Dec 27, 2021 | TARA Protara Therapeutics, Inc. | 10% Owner | Buy | 38,000 | $6.53 | $248,293.39 | +0.7% | -16.9% | -57.9% |